All Stories

  1. Fatal Outcomes in Use of Clozapine

    Article • Journal of Clinical Psychopharmacology, October 2025, Wolters Kluwer Health

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  2. The Crisis of Meaning in Aging and the Expansion of Medically Unjustified Euthanasia: A Psychiatric Imperative

    Article • Actas Españolas de Psiquiatría, October 2025, Juan José López-Ibor Foundation

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  3. Letter to the Editor regarding: “Towards a name change of schizophrenia: positive and negative symptoms disorder (PND)”

    Article • European Archives of Psychiatry and Clinical Neuroscience, September 2025, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  4. On dosing equity, scientific responsibility, and what remains unsaid

    Article • Asian Journal of Psychiatry, August 2025, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  5. Clozapine and Regulatory Inertia: Revisiting Evidence, Risks, and Reform

    Article • Healthcare, July 2025, MDPI AG

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  6. Clozapine-treated patients and myocardial infarction in adults: a pharmacovigilance study in VigiBase interpreted in the context of the literature

    Article • Expert Opinion on Drug Safety, June 2025, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  7. Perceived Stress and Clinical Insomnia in Primary Care: Associations with Lifestyle and Medication Use

    Article • Patient Preference and Adherence, May 2025, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  8. Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I

    Article • Journal of Clinical Psychopharmacology, April 2025, Wolters Kluwer Health

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  9. Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II

    Article • Journal of Clinical Psychopharmacology, April 2025, Wolters Kluwer Health

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  10. The Sleep Expectation–Reality Gap: Exploring Discrepancies Between Perceived and Ideal Sleep Duration in Primary Care Patients

    Article • Healthcare, March 2025, MDPI AG

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  11. Reflections on the Potential and Risks of AI for Scientific Article Writing after the AI Endorsement by Some Scientific Publishers: Focusing on Scopus AI

    Article • Actas Españolas de Psiquiatría, March 2025, Juan José López-Ibor Foundation

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  12. Clozapine pharmacovigilance in Croatia: underreporting of specific adverse drug reactions and excellent reporting of suicide attempts

    Article • Psychiatry Research, February 2025, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  13. The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force

    Article • European Psychiatry, January 2025, Royal College of Psychiatrists

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas, marc de hert

  14. A case of recurrent priapism during prolonged clozapine administration

    Article • Brazilian Journal of Psychiatry, January 2025, FRACTAL EDITORA LTDA

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  15. Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data

    Article • European Child & Adolescent Psychiatry, December 2024, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  16. Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

    Article • Patient Preference and Adherence, November 2024, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  17. Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature

    Article • Expert Opinion on Drug Safety, September 2024, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  18. Exploring the Relationship Between Psychological Constructs and Decision-Making Preferences in Psychiatric Outpatients

    Article • Patient Preference and Adherence, August 2024, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  19. Implications of psychological reactance for clinical practice in psychiatry including a systematic review.

    Article • Motivation Science, July 2024, American Psychological Association (APA)

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  20. Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2024, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  21. Psychoeducational group interventions for adults diagnosed with attention-deficit/ hyperactivity disorder: a scoping review of feasibility, acceptability, and outcome measures

    Article • BMC Psychiatry, June 2024, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  22. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

    Article • Schizophrenia Research, December 2023, Elsevier

    Professor Carlos De las Cuevas, M.D., resident in Psychiatry Renato de Filippis, Professor Carlos De las Cuevas

  23. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database

    Article • Schizophrenia Research, November 2023, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas, M.D., resident in Psychiatry Renato de Filippis

  24. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance

    Article • Schizophrenia Research, November 2023, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  25. Will ChatGPT3 Substitute for us as Clozapine Experts?

    Article • Journal of Clinical Psychopharmacology, September 2023, Wolters Kluwer Health

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  26. Guía internacional Para una dosificación más Segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la Proteína C Reactiva y los niveles de clozapina

    Article • Psiquiatría Biológica, September 2023, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  27. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance

    Article • Schizophrenia Research, September 2023, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  28. Psychiatric Patients’ Perceived Health Control and Reactance: Implications for Medication Adherence

    Article • Patient Preference and Adherence, July 2023, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  29. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients

    Article • Schizophrenia Research, July 2023, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  30. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)

    Article • Schizophrenia Research, June 2023, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  31. Escaping the Long Shadow Cast by Agranulocytosis

    Article • Journal of Clinical Psychopharmacology, April 2023, Wolters Kluwer Health

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  32. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in VigiBase

    Article • Expert Opinion on Drug Metabolism & Toxicology, March 2023, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  33. NURSING STUDENT’S VIEWS ON THE DUTY OF CARE: A CROSS-SECTIONAL STUDY IN TWO COUNTRIES

    Article • The International Journal of Person Centered Medicine, January 2023, University of Buckingham Press

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  34. Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review

    Article • Expert Opinion on Drug Metabolism & Toxicology, December 2022, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  35. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries

    Article • Revista de Psiquiatría y Salud Mental (English Edition), October 2022, Elsevier

    Professor Carlos De las Cuevas

  36. Clozapine-induced myocarditis in Russia: Animal studies but no clinical studies

    Article • Revista de Psiquiatría y Salud Mental (English Edition), October 2022, Elsevier

    Professor Carlos De las Cuevas

  37. Respiratory aspiration during treatment with benzodiazepines, antiepileptic and antidepressant drugs in the pharmacovigilance database from VigiBase

    Article • Expert Opinion on Drug Metabolism & Toxicology, September 2022, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  38. Psychometric Properties of the WHO-5 Well-Being Index among Nurses during the COVID-19 Pandemic: A Cross-Sectional Study in Three Countries

    Article • International Journal of Environmental Research and Public Health, August 2022, MDPI AG

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas, Moises Betancort

  39. Clozapine and the risk of haematological malignancies

    Article • The Lancet Psychiatry, July 2022, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  40. An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine

    Article • General Psychiatry, June 2022, BMJ

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  41. Evaluating the Effect of a Telepsychiatry Educational Program on the Awareness, Knowledge, Attitude, and Skills of Telepsychiatry Among Spanish Psychiatrists during COVID-19 Pandemic

    Article • Telemedicine and e-Health, May 2022, Mary Ann Liebert Inc

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  42. An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s

    Article • European Archives of Psychiatry and Clinical Neuroscience, April 2022, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  43. The duty to care and nurses' well-being during a pandemic

    Article • Nursing Ethics, February 2022, SAGE Publications

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  44. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase

    Article • Expert Review of Clinical Pharmacology, January 2022, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  45. Promoting safer clozapine dosing in the Americas

    Article • Brazilian Journal of Psychiatry, January 2022, FRACTAL EDITORA LTDA

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  46. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Article • Pharmacopsychiatry, December 2021, Thieme Publishing Group

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  47. The Mediating Role of Resilience in the Relationship between Perceived Stress and Mental Health

    Article • International Journal of Environmental Research and Public Health, September 2021, MDPI AG

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas, Moises Betancort

  48. Miocarditis inducida por la clozapina: estudios animales pero no clínicos

    Article • Revista de Psiquiatría y Salud Mental, September 2021, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  49. Clozapine-associated myocarditis in the World Health Organization’s pharmacovigilance database: Focus on reports from various countries

    Article • Revista de Psiquiatría y Salud Mental, July 2021, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  50. Clinimetric Criteria for Patient-Reported Outcome Measures

    Article • Psychotherapy and Psychosomatics, May 2021, Karger Publishers

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  51. Exploring patterns in psychiatric outpatients’ preferences for involvement in decision-making: a latent class analysis approach

    Article • BMC Psychiatry, March 2021, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  52. Effect of necessity‐concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample

    Article • Human Psychopharmacology Clinical and Experimental, January 2021, Wiley

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  53. An update on the complex relationship between clozapine and pneumonia

    Article • Expert Review of Clinical Pharmacology, January 2021, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  54. Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol

    Article • BMJ Open, December 2020, BMJ

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  55. Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics

    Article • Patient Preference and Adherence, October 2020, Taylor & Francis

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  56. Patient-reported well-being: psychometric properties of the world health organization well-being index in specialised community mental health settings

    Article • Psychiatry Research, September 2020, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  57. Assessment of shared decision-making in community mental health care: Validation of the CollaboRATE

    Article • International Journal of Clinical and Health Psychology, August 2020, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  58. Psychometric properties of the Five‐item World Health Organization Well‐being Index used in mental health services: Protocol for a systematic review

    Article • Journal of Advanced Nursing, June 2020, Wiley

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  59. The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase

    Article • Psychological Medicine, May 2020, Cambridge University Press

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  60. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology

    Article • Psychotherapy and Psychosomatics, April 2020, Karger Publishers

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  61. Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics

    Article • World Psychiatry, January 2020, Wiley

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  62. The necessity‐concern framework in the assessment of treatment adherence of psychiatric patients and the role of polypharmacy in a Spanish sample

    Article • Human Psychopharmacology Clinical and Experimental, January 2020, Wiley

    Professor Carlos De las Cuevas, Moises Betancort, Professor Carlos De las Cuevas

  63. Data From the World Health Organization’s Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions

    Article • Schizophrenia Bulletin, September 2019, Oxford University Press (OUP)

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  64. Development and validation of the Patient’s Health Belief Questionnaire on Psychiatric Treatment

    Article • Patient Preference and Adherence, April 2019, Dove Medical Press

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  65. Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - MAPDep: a study protocol for a cluster randomized controlled trial

    Article • Patient Preference and Adherence, February 2019, Dove Medical Press

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  66. Ethnopsychopharmacology study of patients' beliefs regarding concerns about and necessity of taking psychiatric medications

    Article • Human Psychopharmacology Clinical and Experimental, January 2019, Wiley

    Professor Carlos De las Cuevas

  67. A Clinimetric Approach for Improving the Measurement of Pharmacophobia with Replication in Two Other Samples

    Article • Psychotherapy and Psychosomatics, January 2019, Karger Publishers

    Professor Carlos De las Cuevas

  68. Meet Our Editorial Board Member

    Article • Current Drug Safety, September 2018, Bentham Science Publishers

    Professor Carlos De las Cuevas

  69. Predictive validity of the Sidorkiewicz instrument in Spanish: Assessing individual drug adherence in psychiatric patients

    Article • International Journal of Clinical and Health Psychology, May 2018, Elsevier

    Professor Carlos De las Cuevas

  70. Skepticism and pharmacophobia toward medication may negatively impact adherence to psychiatric medications: a comparison among outpatient samples recruited in Spain, Argentina, and Venezuela

    Article • Patient Preference and Adherence, February 2018, Dove Medical Press

    Professor Carlos De las Cuevas, Mariano Motuca, Professor Carlos De las Cuevas

  71. The Art of Pharmacotherapy

    Article • Journal of Clinical Psychopharmacology, April 2017, Wolters Kluwer Health

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  72. Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach

    Article • Patient Preference and Adherence, March 2017, Dove Medical Press

    Professor Carlos De las Cuevas, Dr Wenceslao Peñate, Professor Carlos De las Cuevas, Moises Betancort

  73. Reviving Research on Medication Attitudes for Improving Pharmacotherapy: Focusing on Adherence

    Article • Psychotherapy and Psychosomatics, January 2017, Karger Publishers

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  74. Are Acceptance and Skepticism Determinant Factors for Adherence to Drug Treatment in Psychiatric Patients?

    Article • Journal of Clinical Psychopharmacology, December 2016, Wolters Kluwer Health

    Professor Carlos De las Cuevas

  75. Validity of the Control Preferences Scale in patients with emotional disorders

    Article • Patient Preference and Adherence, November 2016, Dove Medical Press

    Professor Carlos De las Cuevas, Dr Wenceslao Peñate, Professor Carlos De las Cuevas

  76. Perceived Health Control

    Article • The Journal of Clinical Psychiatry, August 2016, Physicians Postgraduate Press, Inc

    Professor Carlos De las Cuevas

  77. Treatment-related decisional conflict in patients with depressive and anxious disorders

    Article • Patient Preference and Adherence, June 2016, Dove Medical Press

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  78. The effect of a brief educational programme added to mental health treatment to improve patient activation: A randomized controlled trial in community mental health centres

    Article • Patient Education and Counseling, May 2016, Elsevier

    Professor Carlos De las Cuevas

  79. Preferencias por las decisiones compartidas en pacientes con depresión

    Article • Acta Colombiana de Psicología, January 2016, Editorial Universidad Catolica de Colombia

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  80. Métodos de valoración de la adherencia al tratamiento psiquiátrico en la práctica clínica

    Article • Revista Iberoamericana de Psicología y Salud, January 2016, Elsevier

    Professor Carlos De las Cuevas

  81. Validation of the General Self-Efficacy Scale in psychiatric outpatient care

    Article • Psicothema, November 2015, Grupo Editorial Psicofundación

    Professor Carlos De las Cuevas

  82. Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence

    Article • Human Psychopharmacology Clinical and Experimental, May 2015, Wiley

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  83. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting

    Article • International Journal of Clinical and Health Psychology, May 2015, Elsevier

    Professor Carlos De las Cuevas

  84. What Do Psychiatric Patients Believe Regarding Where Control Over Their Illness Lies?

    Article • The Journal of Nervous and Mental Disease, February 2015, Wolters Kluwer Health

    Professor Carlos De las Cuevas, Moises Betancort

  85. The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression

    Article • BMC Psychiatry, November 2014, Springer Science + Business Media

    Professor Carlos De las Cuevas

  86. To what extent is treatment adherence of psychiatric patients influenced by their participation in shared decision making?

    Article • Patient Preference and Adherence, November 2014, Dove Medical Press

    Professor Carlos De las Cuevas, Dr Wenceslao Peñate, Professor Luis de Rivera, Professor Carlos De las Cuevas

  87. Psychological reactance in psychiatric patients: Examining the dimensionality and correlates of the Hong Psychological Reactance Scale in a large clinical sample

    Article • Personality and Individual Differences, November 2014, Elsevier

    Professor Carlos De las Cuevas, Moises Betancort

  88. Psychiatric patients’ preferences and experiences in clinical decision-making: Examining concordance and correlates of patients’ preferences

    Article • Patient Education and Counseling, August 2014, Elsevier

    Professor Carlos De las Cuevas

  89. Validation of the Spanish version of the 9-item Shared Decision-Making Questionnaire

    Article • Health Expectations, March 2014, Wiley

    Professor Carlos De las Cuevas

  90. Preferences for participation in shared decision making of psychiatric outpatients with affective disorders

    Article • Open Journal of Psychiatry, January 2014, Scientific Research Publishing, Inc,

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  91. To what extent psychiatric patients feel involved in decision making about their mental health care? Relationships with socio-demographic, clinical, and psychological variables

    Article • Acta Neuropsychiatrica, October 2013, Cambridge University Press

    Professor Carlos De las Cuevas

  92. Risk factors for non-adherence to antidepressant treatment in patients with mood disorders

    Article • European Journal of Clinical Pharmacology, September 2013, Springer Science + Business Media

    Professor Carlos De las Cuevas

  93. Shared decision making in psychiatric practice and the primary care setting is unique, as measured using a 9-item Shared Decision Making Questionnaire (SDM-Q-9)

    Article • Neuropsychiatric Disease and Treatment, July 2013, Taylor & Francis

    Dr Wenceslao Peñate, Professor Carlos De las Cuevas

  94. Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies

    Article • Patient Preference and Adherence, March 2013, Taylor & Francis

    Professor Carlos De las Cuevas

  95. Psychiatric outpatients' self-reported adherence versus psychiatrists' impressions on adherence in affective disorders

    Article • Human Psychopharmacology Clinical and Experimental, March 2013, Wiley

    Professor Carlos De las Cuevas

  96. Estrategias de manejo de los antidepresivos desde la perspectiva de los pacientes: luchando interna y externamente

    Article • Atención Primaria, August 2012, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  97. Attitudes toward concordance in psychiatry: a comparative, cross-sectional study of psychiatric patients and mental health professionals

    Article • BMC Psychiatry, May 2012, Springer Science + Business Media

    Professor Carlos De las Cuevas

  98. Psychiatric patients’ attitudes towards concordance and shared decision making

    Article • Patient Education and Counseling, December 2011, Elsevier

    Professor Carlos De las Cuevas

  99. Mental health professionals' attitudes to partnership in medicine taking: a validation study of the Leeds Attitude to Concordance Scale II

    Article • Pharmacoepidemiology and Drug Safety, September 2011, Wiley

    Professor Carlos De las Cuevas

  100. ¿Están relacionadas la obesidad y otras comorbilidades físicas con la enfermedad mental?

    Article • Revista de Psiquiatría y Salud Mental, July 2011, Elsevier

    Professor Carlos De las Cuevas

  101. Editorial [Hot Topic: Compliance, Adherence and Concordance in Medicine Taking of Psychiatric Patients (Guest Editor: Carlos De las Cuevas)]

    Article • Current Clinical Pharmacology, May 2011, Bentham Science Publishers

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  102. Towards a Clarification of Terminology in Medicine Taking Behavior: Compliance, Adherence and Concordance are Related Although Different Terms with Different Uses

    Article • Current Clinical Pharmacology, May 2011, Bentham Science Publishers

    Professor Carlos De las Cuevas

  103. Adaptation and validation study of the Beliefs about Medicines Questionnaire in psychiatric outpatients in a community mental health setting

    Article • Human Psychopharmacology Clinical and Experimental, March 2011, Wiley

    Professor Carlos De las Cuevas

  104. Antidepressant Use in Early Pregnancy

    Article • Current Women s Health Reviews, February 2011, Bentham Science Publishers

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  105. Lithium Use During Early, Late Pregnancy, and Breastfeeding

    Article • Current Women s Health Reviews, February 2011, Bentham Science Publishers

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  106. Psychomotor performance and fitness to drive: The influence of psychiatric disease and its pharmacological treatment

    Article • Psychiatry Research, April 2010, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  107. Versión española consensuada de la Severity of Dependence Scale (SDS)

    Article • Medicina Clínica, December 2008, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  108. Fitness to Drive of Psychiatric Patients

    Article • The Primary Care Companion to The Journal of Clinical Psychiatry, October 2008, Physicians Postgraduate Press, Inc

    Professor Carlos De las Cuevas

  109. Attitudes toward psychiatric drug treatment: the experience of being treated

    Article • European Journal of Clinical Pharmacology, August 2007, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  110. Duloxetine-Induced Excessive Disturbing and Disabling Yawning

    Article • Journal of Clinical Psychopharmacology, February 2007, Wolters Kluwer Health

    Professor Carlos De las Cuevas

  111. Are psychotropics drugs used in pregnancy?

    Article • Pharmacoepidemiology and Drug Safety, January 2007, Wiley

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  112. Randomized Clinical Trial of Telepsychiatry through Videoconference versus Face-to-Face Conventional Psychiatric Treatment

    Article • Telemedicine and e-Health, June 2006, Mary Ann Liebert Inc

    Professor Carlos De las Cuevas

  113. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy

    Article • Current Drug Safety, January 2006, Bentham Science Publishers

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  114. Polypsychopharmacy

    Article • Journal of Clinical Psychopharmacology, October 2005, Wolters Kluwer Health

    Professor Carlos De las Cuevas

  115. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

    Article • The Lancet, February 2005, Elsevier

    Professor Carlos De las Cuevas

  116. Telepsychiatry: Psychiatric consultation through videoconference patients' perception and satisfaction

    Article • January 2005, American Psychological Association (APA)

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  117. Telepsychiatry: Psychiatric consultation through videoconference clinical results

    Article • January 2005, American Psychological Association (APA)

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  118. Polypharmacy in psychiatric practice in the Canary Islands

    Article • BMC Psychiatry, July 2004, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  119. Do therapeutic indications of antidepressants change from one year to another?

    Article • Pharmacoepidemiology and Drug Safety, May 2004, Wiley

    Professor Carlos De las Cuevas

  120. Telepsychiatry in the Canary Islands: user acceptance and satisfaction

    Article • Journal of Telemedicine and Telecare, August 2003, SAGE Publications

    Professor Carlos De las Cuevas

  121. Telepsiquiatría: utopía o realidad asistencial

    Article • Medicina Clínica, June 2003, Elsevier

    Professor Carlos De las Cuevas

  122. Benzodiazepines: more "behavioural" addiction than dependence

    Article • Psychopharmacology, April 2003, Springer Science + Business Media

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  123. Burnout en los profesionales de la atención a las drogodependencias

    Article • Trastornos Adictivos, January 2003, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  124. Telepsiquiatría: utopía o realidad asistencial

    Article • Medicina Clínica, January 2003, Elsevier

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  125. Variations in antidepressant prescribing practice: clinical need or market influences?

    Article • Pharmacoepidemiology and Drug Safety, January 2002, Wiley

    Professor Carlos De las Cuevas, Professor Carlos De las Cuevas

  126. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study

    Article • Addiction, February 2000, Wiley

    Professor Carlos De las Cuevas

  127. Benzodiazepine prescription is different in the public and private sectors

    Article • Pharmacoepidemiology and Drug Safety, August 1999, Wiley

    Professor Carlos De las Cuevas

  128. Prescribed daily doses and ‘risk factors’ associated with the use of benzodiazepines in primary care

    Article • Pharmacoepidemiology and Drug Safety, May 1999, Wiley

    Professor Carlos De las Cuevas

  129. Benzodiazepine audit in primary care

    Article • European Neuropsychopharmacology, November 1998, Elsevier

    Professor Carlos De las Cuevas

  130. PSYCHOPATHOLOGICAL PROFILE IN ANXIETY DISORDERS

    Article • Behavioural Pharmacology, April 1992, Wolters Kluwer Health

    Professor Carlos De las Cuevas

  131. INSOMNIA AND AFFECTIVE DISORDERS

    Article • Behavioural Pharmacology, April 1992, Wolters Kluwer Health

    Professor Carlos De las Cuevas